SENS
HEALTHCARESenseonics Holdings Inc
$5.36+0.36 (+7.20%)PRE
Live · AMEX · May 9, Close
AI Insight
What's Moving SENS Today?
No stock-specific AI insight has been generated for SENS yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$4.79$14.50
$5.36
Fundamentals
Market Cap$280M
P/E Ratio—
EPS$-1.66
Dividend Yield—
Dividend / Share—
ROE-1.7%
Profit Margin-2.0%
Debt / Equity—
Trading
Volume1.7M
Avg Volume (10D)—
Shares Outstanding52.2M
SENS News
22 articles- Senseonics Holdings, Inc. Common Stock Q1 Earnings Call HighlightsMarketbeat·May 9, 2026
- Senseonics Holdings (SENS) Reports Q1 Loss, Beats Revenue EstimatesYahoo Finance·May 7, 2026
- Senseonics Holdings, Inc. Reports First Quarter 2026 Financial ResultsYahoo Finance·May 7, 2026
- Senseonics Announces Closing of $92 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesYahoo Finance·May 4, 2026
- Senseonics Enters Into Amended Loan Agreement with Hercules to Increase Borrowing Capacity to $140 MillionYahoo Finance·May 4, 2026
- Top Midday DeclinersYahoo Finance·May 1, 2026
- Senseonics Holdings, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call for May 7, 2026 at 4:30 P.M. Eastern TimeYahoo Finance·May 1, 2026
- Senseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded WarrantsYahoo Finance·May 1, 2026
- Senseonics Announces Commencement of $80 Million Public Offering of Common Stock and Pre-Funded WarrantsYahoo Finance·Apr 30, 2026
- Middle East and Africa Continuous Glucose Monitoring Market Forecast and Company Analysis Report 2026-2034 Featuring Dexcom, Medtronic, Senseonics, Abbott Diabetes Care, and GlySensGlobeNewswire Inc.·Apr 29, 2026
- Senseonics Announces European Launch of Eversense® 365, The World’s First and Only One Year CGM SystemGlobeNewswire Inc.·Apr 24, 2026
- Study Supports GlucoTrack’s Blood Glucose Monitoring ImplantYahoo Finance·Apr 21, 2026
- 3 European Stocks Estimated To Be Trading At Discounts Of Up To 48.2%Yahoo Finance·Apr 16, 2026
- MedTech's Edge: How AI and Remote Diagnostics Drive Scalable ValueBenzinga·Mar 27, 2026
- Johnson & Johnson Exits 3 Biotechs but Keeps Stakes in These Rumored Acquisition TargetsYahoo Finance·Mar 25, 2026
- Senseonics Reports Strong One-Year Real-World Data for Eversense 365Yahoo Finance·Mar 17, 2026
- First Ever Real-World Evidence of Eversense 365 Presented at ATTD Demonstrates Sustained Performance and Positive Impact Throughout One-Year of WearYahoo Finance·Mar 14, 2026
- Wall Street Analysts Predict a 124.49% Upside in Senseonics (SENS): Here's What You Should KnowYahoo Finance·Mar 3, 2026
- Senseonics Holdings, Inc. Q4 2025 Earnings Call SummaryMoby·Mar 3, 2026
- Senseonics Holdings Inc (SENS) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid ...Yahoo Finance·Mar 3, 2026
- Senseonics Holdings, Inc. Common Stock Q4 Earnings Call HighlightsMarketbeat·Mar 3, 2026
- Senseonics Holdings (SENS) Reports Q4 Loss, Tops Revenue EstimatesYahoo Finance·Mar 2, 2026
All 22 articles loaded
Price Data
Open$5.00
Previous Close$5.00
Day High$5.47
Day Low$4.91
52 Week High$14.50
52 Week Low$4.79
52-Week Range
$4.79$14.50
$5.36
Fundamentals
Market Cap$280M
P/E Ratio—
EPS$-1.66
Dividend Yield—
Dividend / Share—
ROE-1.7%
Profit Margin-2.0%
Debt / Equity—
Trading
Volume1.7M
Avg Volume (10D)—
Shares Outstanding52.2M
About Senseonics Holdings Inc
Senseonics Holdings, Inc., a medical technology company, develops and markets continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company is headquartered in Germantown, Maryland.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeStock
ExchangeAMEX
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—